oveporexton

all catalysts(0)

nothing on the calendar yet

News(2)

• Takeda’s narcolepsy nod opens orexin doors
  Orzeyful is the first orexin agonist cleared by the FDA, and is the first narcolepsy therapy that addresses the full host of disease symptoms. It is "likely to reshape the treatment paradigm” for t…
  biospace · 8d ago
• FDA Approves First Drug to Treat the Full Range of Narcolepsy Type 1 Symptoms
  The FDA approved Orzeyful (oveporexton) tablets for the treatment of narcolepsy type 1 in adults.
  fda_press · 9d ago